BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9625847)

  • 1. Collecting duct carcinomas of the kidney: a comparative loss of heterozygosity study with clear cell renal cell carcinoma.
    Fogt F; Zhuang Z; Linehan WM; Merino MJ
    Oncol Rep; 1998; 5(4):923-6. PubMed ID: 9625847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney.
    Schoenberg M; Cairns P; Brooks JD; Marshall FF; Epstein JI; Isaacs WB; Sidransky D
    Genes Chromosomes Cancer; 1995 Jan; 12(1):76-80. PubMed ID: 7534117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma.
    Petersson F; Grossmann P; Hora M; Sperga M; Montiel DP; Martinek P; Gutierrez ME; Bulimbasic S; Michal M; Branzovsky J; Hes O
    Hum Pathol; 2013 Jul; 44(7):1412-20. PubMed ID: 23434146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.
    Martinez A; Fullwood P; Kondo K; Kishida T; Yao M; Maher ER; Latif F
    Mol Pathol; 2000 Jun; 53(3):137-44. PubMed ID: 10897333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
    Velickovic M; Delahunt B; McIver B; Grebe SK
    Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus.
    Velickovic M; Delahunt B; Grebe SK
    Cancer Res; 1999 Mar; 59(6):1323-6. PubMed ID: 10096566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p14.1;q24.23) family.
    Valle L; Cascón A; Melchor L; Otero I; Rodríguez-Perales S; Sánchez L; Cruz Cigudosa J; Robledo M; Weber B; Urioste M; Benítez J
    Eur J Hum Genet; 2005 May; 13(5):570-8. PubMed ID: 15756303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the VHL tumour suppressor gene in renal carcinoma.
    Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
    Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
    He Z; Liu S; Guo M; Mao J; Hughson MD
    Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
    Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number profiling in von Hippel-Lindau disease renal cell carcinoma.
    Shuib S; Wei W; Sur H; Morris MR; McMullan D; Rattenberry E; Meyer E; Maxwell PH; Kishida T; Yao M; Latif F; Maher ER
    Genes Chromosomes Cancer; 2011 Jul; 50(7):479-88. PubMed ID: 21456047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.
    Banks RE; Tirukonda P; Taylor C; Hornigold N; Astuti D; Cohen D; Maher ER; Stanley AJ; Harnden P; Joyce A; Knowles M; Selby PJ
    Cancer Res; 2006 Feb; 66(4):2000-11. PubMed ID: 16488999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.
    Schraml P; Struckmann K; Bednar R; Fu W; Gasser T; Wilber K; Kononen J; Sauter G; Mihatsch MJ; Moch H
    Am J Pathol; 2001 Feb; 158(2):593-601. PubMed ID: 11159196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway.
    Yamamoto S; Tsuda H; Suzuki K; Takano M; Tamai S; Matsubara O
    Virchows Arch; 2009 Sep; 455(3):261-70. PubMed ID: 19655165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
    Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
    Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.